You are on page 1of 5

Industry Structure

Types of Pharma Companies

Generic

Branded

Ranbaxy, Glenmark, Cipla, Dr. Reddy

Pfizer, Sun Pharmaceuticals , Glaxosmith Kline, Aristo

Macro view
Global pharmaceutical market
~US$ 1 trillion in 2013, up from US$ 956 billion in 2011

Indian Pharmaceutical Market


Industry grew at a 5 year CAGR of about 1718% and reache d a market size of ~ US$ 30 bn in 20111 2

Outlook on Opportunities
Annual global spend is expected to more than double to US$ 70 billion by 2016 from US$ 30 billion in 2012

Market is forecasted to grow at a CAGR of 3-6% over 2012-16 to

Expected

US$ 1.1-1.2 trillion in sales by 2016

to grow at a CAGR of 15% to ~US$ 29 billion in 2016

Focus on US and the pharmerging markets

Source : Ranbaxy Annual Report 2012

Global Pharma Market Break-up


South Korea 1% Rest of Europe 7% Canada 2% Rest of Europe 5% South Korea 1% Rest of World 8% USA 31%

Rest of World 7% USA 34%

Canada 2%

Pharmerging 20% EU 17% Japan 12%

Pharmerging 30% EU 13% Japan 10%

2011

2016
Source : CRISIL Research & Ranbaxy Annual Report 2012

PEST ANALYSIS
P
Political
Each nation has its own system for ensuring safety of distribution for drugs

Economical
Exchange rate Inflation Cost of Capital

High taxation

Social
Working with NGO to spread importance of Health issues
Free medical Camps

Technological
Technological advancement

Automation
Outsourcing

Regulatory Framework & Key Issues


What are the regulatory mechanisms followed in India? Which are the major regulatory bodies in India and how are their actions coordinated? What is the approval process for an NDA?

You might also like